Researchers at the University of California, Davis have developed tactile feedback systems that enhance spatial and sensory resolution in sensor arrays through unique signal modulation techniques.

Scaled neural sensing has been pursued for decades. Physical limitations associated with electrical (electrode-based) field recordings hinder advances in both field of view and spatial resolution. Electrochromic plasmonics (electro-plasmonics) has emerged as a rapidly advancing field combining traditional electrochromic materials with plasmonic nanostructures, including recent demonstrations of electrochromic-loaded plasmonic nanoantennas for optical voltage sensing. Existing optical electrophysiology techniques face critical limitations including poor signal-to-noise ratios due to low photon counts from genetically encoded voltage indicators, which have small cross-sections and low quantum yields. Fluorescent voltage indicators suffer from photobleaching, phototoxicity, and require genetic modifications that limit their clinical applicability. Current electrochromic devices also struggle with limited cycling stability, slow switching times, and restricted color options, and conventional plasmonic sensors exhibit inherently low electric field sensitivity due to high electron densities of metals like gold and silver. Current approaches to electro-plasmonics lack stable, high-contrast optical modulators that can operate at sub-millisecond speeds while maintaining human biocompatibility.

This technology introduces a novel approach for bridging force sensing with wireless communication through direct analog force-to-RF conversion provides lower power consumption and lower costs.

A novel sensor device leveraging hydrogel and metallic structures for passive, wireless environmental monitoring.

A novel device leveraging centrifugal microfluidics to accelerate bacterial growth and rapidly determine antibiotic susceptibility.

This technology enhances the sensitivity of sensors through exceptional points of degeneracy in various circuit configurations.

A novel circuit design promoting enhanced sensitivity for electromagnetic sensing through exceptional points of degeneracy.

An innovative technique for creating high-sensitivity Whispering Gallery Mode (WGM) sensors through advanced microbubble resonator fabrication.

An innovative system for biometric identification that utilizes intra-body communication for secure authentication.

A revolutionary approach to wearable sensors that significantly extends read-out distances and improves reliability without the need for microelectronics.

This technology introduces a flexible, secure, and scalable approach to creating body area networks (BANs) using textile-integrated metamaterials for advanced healthcare monitoring.

Sensors are used in a multitude of applications from molecular biology, chemicals detection to wireless communications. Researchers at the University of California Irvine have invented a new type of electronic circuit that utilizes exceptional points of degeneracy to improve the sensitivity of signal detection.

A revolutionary device for the diagnosis of cerebrospinal fluid (CSF) leaks with rapid, accurate, and low-volume sampling at the point of care.

      Poorly designed healthcare environments can increase patient stress and delay recovery, particularly in pediatric settings (see, e.g., Devlin & Andrade 2017; Park et al. 2018; Jafarifiroozabadi et al. 2023). Traditional methods for gathering architectural design feedback, such as interviews, surveys, and focus groups, rely heavily on subjective user input, and often fail to capture the voices of children by relying on parent proxies. Physical mock-ups, a common alternative to traditional methods, provide a full-scale model of a room or space, often constructed from materials like cardboard or foam. While these mock-ups allow for some degree of spatial exploration, they are time-intensive, and limited in their ability to replicate real-world conditions; high-fidelity mock-ups which incorporate more realistic materials and finishes add expense and limit flexibility for testing multiple design iterations.       To overcome these challenges UC Berkeley researchers have developed an innovative participatory design methodology that leverages advanced virtual reality (VR), eye-tracking, and physiological/emotional biofeedback technologies to evaluate the design of pediatric healthcare environments. This comprehensive system is further enhanced by custom-developed workflows for creating dynamic, interactive room simulations that are randomized to ensure rigorous, unbiased data collection. The methodology is uniquely capable of gathering objective, quantifiable data on how pediatric patients and their families respond physiologically and emotionally to specific environmental design features.

Brief description not available

Researchers at the University of California, Davis have developed a solid-state device that uses Cherenkov Radiation to emit light at a tunable wavelength in the THz to IR range.

Researchers at the University of California, Davis have developed an algorithm for designing and identifying complex structures having custom release profiles for controlled drug delivery.

      Biologics are antibodies produced by genetically engineered cells and are widely used in therapeutic applications. Examples include pembrolizumab (Keytruda) and atezolizumab (Tecentriq), both employed in cancer immunotherapy as checkpoint inhibitors to restore T- cell immune responses against tumor cells. These biologics are produced by engineered cells in bioreactors in a process that is highly sensitive to the bioreactor environment, making it essential to integrate process analytical technologies (PAT) for closed-loop, real-time adjustments. Recent trends have focused on leveraging integrated circuit (IC) solutions for system miniaturization and enhanced functionality, for example enabling a single IC that monitors O2, pH, oxidation-reduction potential (ORP), temperature, and glucose levels. However, no current technology can directly and continuously quantify the concentration and quality of the produced biologics in real-time within the bioreactor. Such critical measurements still rely on off-line methods such as immunoassays and mass spectrometry, which are time-consuming and not suitable for real- time process control.       UC Berkeley researchers have developed a microsystem for real-time, in-vivo monitoring of antibody therapeutics using structure-switching aptamers by employing an integrator-based readout front-end. This approach effectively addresses the challenge of a 100× reduction in signal levels compared to the measurement of small-molecule drugs in prior works. The microsystem is also uniquely suited to the emerging paradigm of “living pharmacies.” In living pharmacies, drug-producing cells will be hosted on implantable devices, and real-time monitoring of drug production/diffusion rates based on an individual’s pharmokinetics will be crucial.

      Current clinical practice for detecting low-concentration molecular biomarkers requires sending samples to centralized labs, leading to high costs and delays. Successful point-of-care (POC) diagnostic technology exist, such as the paper-based lateral-flow assay (LFA) used for pregnancy tests and SARS-CoV-2 rapid antigen tests, or miniaturized instruments such as the Abbot i-Stat Alinity. However, the former provides binary results or limited quantitative accuracy, and the latter is too expensive for in-home deployment. A promising approach for POC diagnostics, offering tailored circuit optimization, multiplexed detection, and significant cost and size reductions, is millimeter-sized CMOS integrated circuits coupled with microfluidics. Recent demonstrations include protein, DNA/RNA, and cell detection. The current complexity of system packaging (e.g., wire/flip-chip bonding) makes integrating microfluidics with more sophisticated functions challenging, and often-required syringe pumps and tubing are operationally unfriendly, limiting current approaches.       UC Berkeley researchers have developed a fully integrated, multi-mode POC device that requires single-step assembly and operates autonomously. Drawing inspiration from RFID technology and implantables, they have introduced inductively-coupled wireless powering and communication functionality into a CMOS bio-analyzer. With the chip being fully wireless, the die can be easily integrated into a substrate carrier, achieving a completely flat surface that allows for seamless bonding with the microfluidic module. In the final product, the device will be sealed in a pouch inside a vacuum desiccator. The user tears the pouch, adds a drop of sample, and the system automatically begins operation. The operation window can last up to 40 minutes, making the process insensitive to time delays. The present CMOS bio-analyzer integrates pH-sensing and amperometric readout circuits for both proton-based and redox-based immunoassays.

      Integrating microelectronics with microfluidics, especially those implemented in silicon-based CMOS technology, has driven the next generation of in vitro diagnostics. CMOS/microfluidics platforms offer (1) close interfaces between electronics and biological samples, and (2) tight integration of readout circuits with multi-channel microfluidics, both of which are crucial factors in achieving enhanced sensitivity and detection throughput. Conventionally bulky benchtop instruments are now being transformed into millimeter-sized form factors at low cost, making the deployment for Point-of-Care (PoC) applications feasible. However, conventional CMOS/microfluidics integration suffers from significant misalignment between the microfluidics and the sensing transducers on the chip, especially when the transducer sizes are reduced or the microfluidic channel width shrinks, due to limitations of current fabrication methods.       UC Berkeley researchers have developed a novel methodology for fabricating microfluidics platforms closely embedded within a silicon chip implemented in CMOS technology. The process utilizes a one-step approach to create fluidic channels directly within the CMOS technology and avoids the previously cited misalignment. Three types of structures are presented in a TSMC 180-nm CMOS chip: (1) passive microfluidics in the form of a micro-mixer and a 1:64 splitter, (2) fluidic channels with embedded ion-sensitive field-effect transistors (ISFETs) and Hall sensors, and (3) integrated on-chip impedance-sensing readout circuits including voltage drivers and a fully differential transimpedance amplifier (TIA). Sensors and transistors are functional pre- and post-etching with minimal changes in performance. Tight integration of fluidics and electronics is achieved, paving the way for future small-size, high-throughput lab-on-chip (LOC) devices.

Researchers at the University of California, Davis have developed a technology that provides a novel method for decoding biosignals into speech, enhancing communication for individuals with speech impairments.

A groundbreaking technology that mimics the dynamic color-changing functionality of the blue-ringed octopus for applications in camouflage, signaling, and beyond.

Researchers at the University of California, Davis have developed a technology that offers a sophisticated solution for collecting and measuring gas emissions from surfaces, particularly skin, with high sensitivity and specificity.

This technology revolutionizes health monitoring by integrating smart textiles with body area networks for real-time biometric data collection.

Brief description not available